Acta neurologica belgica regarding the manuscript entitled ‘Safety and efficacy of extended versus standard interval dosing of natalizumab in multiple sclerosis patients: a systematic review and meta-analysis’

Journal Contribution ResearchOnline@JCU
Boggild, Mike;Mohammadpour, Zinat;van Eijk, Liza;Williams, Lachlan
Zinat Mohammadpour
Abstract

[Extract] We read the recent meta-analysis by Rabea et al. with interest [1]. The authors compare the safety and efficacy of extended interval dosing (EID) versus standard interval dosing (SID) of natalizumab in patients with multiple sclerosis (MS) [1]. While we agree that the data supports comparable clinical and radiological efficacy for SID and EID, we are concerned that the analysis does not reflect the probable relative safety of these dosing strategies.

Journal

Acta Neurologica Belgica

Publication Name

Acta Neurologica Belgica

Volume

126

ISBN/ISSN

2240-2993

Edition

N/A

Issue

N/A

Pages Count

2

Location

N/A

Publisher

Springer

Publisher Url

N/A

Publisher Location

N/A

Publish Date

N/A

Url

N/A

Date

N/A

EISSN

N/A

DOI

10.1007/s13760-025-02781-4